Medipharm Labs Interview with Proactive Investors
Medipharm Labs Interview with Proactive Investors
Perth, Sep 20, 2018 AEST (ABN Newswire) - MMJ PhytoTech Limited (ASX:MMJ) (OTCMKTS:MMJJF) ("MMJ") is pleased to note the interview with Proactive Investors Vancouver given by Pat McCutcheon, President and CEO of MediPharm Labs, Inc. ("MediPharm Labs"), providing a detailed description of their business and revenue model.

The interview can be viewed at: http://www.abnnewswire.net/lnk/ZLIFSM6L

MMJ owns 6.9% of MediPharm Labs.


About MMJ Group Holdings Ltd

Phytotech Medical ASX:PYL

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: http://www.mmjphytotech.com.au/investors/

   


Contact

Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819
E: info@mmjgh.com.au



Related Companies

MMJ Group Holdings Ltd   

ABN Newswire This Page Viewed:  (Last 7 Days: 40) (Last 30 Days: 182) (Since Published: 1534) 
ANALYTICS: LOGIN HERE

MMJ Group Holdings Ltd NEWS: RECENT VISITS (44464)

Research Report

Social Media